Tapewire

NYSE · USD

HUM

HUMANA INC

Export transactions ↓
Tapewire entity
1429
SEC CIK
0000049071
Parsed reports
738

Last 12 months

Inside the activity.

1 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202610
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
December 31, 2025 Filed Jan 5, 2026 19:19 UTC GrantRestricted Stock Units · Derivative 35 $258.87 $9,060.36
Disclosure

SEC source: 0001802241-26-000002 · form4.xml · derivative · entry 3

Frederick Wayne A.I. · CIK 0001802241 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 73

Underlying: Humana Common · 35 shares

Expires not disclosed

F2 · security: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

F2 · derivative.exercise_price: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

F2 · derivative.exercise_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

F2 · derivative.expiration_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

Read SEC document
December 31, 2025 Filed Jan 5, 2026 18:52 UTC GrantRestricted Stock Units · Derivative 16 $258.87 $4,141.88
Disclosure

SEC source: 0001646121-26-000003 · form4.xml · derivative · entry 3

Garratt John W · CIK 0001646121 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18

Underlying: Humana Common · 16 shares

Expires not disclosed

F2 · security: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

F2 · derivative.exercise_price: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

F2 · derivative.exercise_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

F2 · derivative.expiration_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

Read SEC document
December 31, 2025 Filed Jan 5, 2026 18:47 UTC GrantRestricted Stock Units · Derivative 28 $258.87 $7,248.29
Disclosure

SEC source: 0001692367-26-000003 · form4.xml · derivative · entry 3

Klevorn Marcy S · CIK 0001692367 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 53

Underlying: Humana Common · 28 shares

Expires not disclosed

F2 · security: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until her resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

F2 · derivative.exercise_price: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until her resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

F2 · derivative.exercise_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until her resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

F2 · derivative.expiration_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until her resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

Read SEC document
December 31, 2025 Filed Jan 5, 2026 18:24 UTC GrantRestricted Stock Units · Derivative 357 $258.87 $92,415.70
Disclosure

SEC source: 0001191504-26-000002 · form4.xml · derivative · entry 4

HILZINGER KURT J · CIK 0001191504 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,765

Underlying: Humana Common · 357 shares

Expires not disclosed

F3 · security: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person during a designated enrollment period in the year preceding the reported transactions. Stock units will be payable in Humana Inc. common stock on a 1-for-1basis, exempt pursuant to Rule 16(b)-3(d)(1), per the Director's election.

F3 · derivative.exercise_price: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person during a designated enrollment period in the year preceding the reported transactions. Stock units will be payable in Humana Inc. common stock on a 1-for-1basis, exempt pursuant to Rule 16(b)-3(d)(1), per the Director's election.

F3 · derivative.exercise_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person during a designated enrollment period in the year preceding the reported transactions. Stock units will be payable in Humana Inc. common stock on a 1-for-1basis, exempt pursuant to Rule 16(b)-3(d)(1), per the Director's election.

F3 · derivative.expiration_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person during a designated enrollment period in the year preceding the reported transactions. Stock units will be payable in Humana Inc. common stock on a 1-for-1basis, exempt pursuant to Rule 16(b)-3(d)(1), per the Director's election.

Read SEC document
December 31, 2025 Filed Jan 5, 2026 18:24 UTC GrantRestricted Stock Units · Derivative 611 $258.87 $158,168.04
Disclosure

SEC source: 0001191504-26-000002 · form4.xml · derivative · entry 3

HILZINGER KURT J · CIK 0001191504 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,364

Underlying: Humana Common · 611 shares

Expires not disclosed

F2 · security: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

F2 · derivative.exercise_price: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

F2 · derivative.exercise_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

F2 · derivative.expiration_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

Read SEC document
December 31, 2025 Filed Jan 5, 2026 14:31 UTC
KATZ KARENDirector
GrantRestricted Stock Units · Derivative 49 $258.87 $12,684.51
Disclosure

SEC source: 0001157619-26-000003 · form4.xml · derivative · entry 4

KATZ KAREN · CIK 0001157619 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 124

Underlying: Humana Common · 49 shares

Expires not disclosed

F3 · security: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until her resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

F3 · derivative.exercise_price: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until her resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

F3 · derivative.exercise_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until her resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

F3 · derivative.expiration_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until her resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

Read SEC document
December 31, 2025 Filed Jan 5, 2026 14:02 UTC
Smith GordonDirector
GrantRestricted Stock Units · Derivative 10 $258.87 $2,588.68
Disclosure

SEC source: 0001311487-26-000002 · form4.xml · derivative · entry 4

Smith Gordon · CIK 0001311487 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10

Underlying: Humana Common · 10 shares

Expires not disclosed

F3 · derivative.exercise_price: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

F3 · derivative.exercise_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

F3 · derivative.expiration_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

F3 · balance_after: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

Read SEC document
December 31, 2025 Filed Jan 5, 2026 14:02 UTC
Smith GordonDirector
GrantRestricted Stock Units · Derivative 122 $258.87 $31,581.84
Disclosure

SEC source: 0001311487-26-000002 · form4.xml · derivative · entry 3

Smith Gordon · CIK 0001311487 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 500

Underlying: Humana Common · 122 shares

Expires not disclosed

F2 · derivative.exercise_price: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person during a designated enrollment period in the year preceding the reported transactions. Stock units will be payable in Humana Inc. common stock on a 1-for-1basis, exempt pursuant to Rule 16(b)-3(d)(1), per the Director's election.

F2 · derivative.exercise_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person during a designated enrollment period in the year preceding the reported transactions. Stock units will be payable in Humana Inc. common stock on a 1-for-1basis, exempt pursuant to Rule 16(b)-3(d)(1), per the Director's election.

F2 · derivative.expiration_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person during a designated enrollment period in the year preceding the reported transactions. Stock units will be payable in Humana Inc. common stock on a 1-for-1basis, exempt pursuant to Rule 16(b)-3(d)(1), per the Director's election.

F2 · balance_after: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person during a designated enrollment period in the year preceding the reported transactions. Stock units will be payable in Humana Inc. common stock on a 1-for-1basis, exempt pursuant to Rule 16(b)-3(d)(1), per the Director's election.

Read SEC document
December 31, 2025 Filed Jan 5, 2026 13:57 UTC GrantRestricted Stock Units · Derivative 34 $258.87 $8,801.50
Disclosure

SEC source: 0001823759-26-000005 · form4.xml · derivative · entry 3

Bono Raquel C. · CIK 0001823759 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 72

Underlying: Humana Common · 34 shares

Expires not disclosed

F2 · security: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until her resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

F2 · derivative.exercise_price: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until her resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

F2 · derivative.exercise_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until her resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

F2 · derivative.expiration_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until her resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

Read SEC document
December 15, 2025 Filed Dec 17, 2025 20:12 UTC
Mellet CelesteChief Financial Officer
Tax withholdingHumana Common 1,222 $270.16 $330,129.41
Disclosure

SEC source: 0001748812-25-000008 · form4.xml · nonDerivative · entry 2

Mellet Celeste · CIK 0001748812 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,454

F2 · shares: Shares disposed of represent payment of tax liability for shares vesting 12/15/25 in which no value was received in return.

F1 · balance_after: Includes 27,548 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan.

Read SEC document
December 15, 2025 Filed Dec 17, 2025 20:12 UTC
Mellet CelesteChief Financial Officer
Exercise / conversionHumana Common 2,128 $0.00 $0.00
Disclosure

SEC source: 0001748812-25-000008 · form4.xml · nonDerivative · entry 1

Mellet Celeste · CIK 0001748812 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,676

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 15, 2025 Filed Dec 17, 2025 20:00 UTC
Mehta JapanChief Information Officer
Tax withholdingHumana Common 470 $270.16 $126,972.85
Disclosure

SEC source: 0002053625-25-000003 · form4.xml · nonDerivative · entry 2

Mehta Japan · CIK 0002053625 · Chief Information Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,158

F2 · shares: Shares disposed of represent payment of tax liability for shares vesting on 12/15/25. No value was received in return.

F1 · balance_after: Includes 7,434 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan.

Read SEC document
December 15, 2025 Filed Dec 17, 2025 20:00 UTC
Mehta JapanChief Information Officer
Exercise / conversionHumana Common 1,194 $0.00 $0.00
Disclosure

SEC source: 0002053625-25-000003 · form4.xml · nonDerivative · entry 1

Mehta Japan · CIK 0002053625 · Chief Information Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,628

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 15, 2025 Filed Dec 17, 2025 19:58 UTC
Dintenfass DavidPresident, Enterprise Growth
Tax withholdingHumana Common 918 $270.16 $248,002.29
Disclosure

SEC source: 0002010288-25-000003 · form4.xml · nonDerivative · entry 2

Dintenfass David · CIK 0002010288 · President, Enterprise Growth

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,316

F3 · shares: Shares disposed of represent payment for tax liability on restricted stock units vested on 12/15/25.

F2 · balance_after: Includes 11,202 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan.

Read SEC document
December 15, 2025 Filed Dec 17, 2025 19:58 UTC
Dintenfass DavidPresident, Enterprise Growth
Exercise / conversionHumana Common 2,032 $0.00 $0.00
Disclosure

SEC source: 0002010288-25-000003 · form4.xml · nonDerivative · entry 1

Dintenfass David · CIK 0002010288 · President, Enterprise Growth

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,234

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 15, 2025 Filed Dec 17, 2025 19:15 UTC
Shetty Sanjay KPresident, CenterWell
Exercise / conversionRestricted Stock Units · Derivative 308 $0.00 $0.00
Disclosure

SEC source: 0001969331-25-000003 · form4.xml · derivative · entry 7

Shetty Sanjay K · CIK 0001969331 · President, CenterWell

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Humana Common · 308 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F3 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F4 · derivative.exercise_date: Restricted stock units granted to reporting person on 4/1/2023, 33% of the award is vesting on 12/15/23, 12/15/24, and 12/15/25.

F4 · derivative.expiration_date: Restricted stock units granted to reporting person on 4/1/2023, 33% of the award is vesting on 12/15/23, 12/15/24, and 12/15/25.

Read SEC document
December 15, 2025 Filed Dec 17, 2025 19:15 UTC
Shetty Sanjay KPresident, CenterWell
Tax withholdingHumana Common 139 $270.16 $37,551.55
Disclosure

SEC source: 0001969331-25-000003 · form4.xml · nonDerivative · entry 4

Shetty Sanjay K · CIK 0001969331 · President, CenterWell

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,847

F6 · shares: Shares disposed of represent payment of tax liability for shares vesting 12/15/25. No value was received in return.

F5 · balance_after: Includes 8,818 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan.

Read SEC document
December 15, 2025 Filed Dec 17, 2025 19:15 UTC
Shetty Sanjay KPresident, CenterWell
Exercise / conversionHumana Common 308 $0.00 $0.00
Disclosure

SEC source: 0001969331-25-000003 · form4.xml · nonDerivative · entry 3

Shetty Sanjay K · CIK 0001969331 · President, CenterWell

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,986

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 15, 2025 Filed Dec 17, 2025 19:15 UTC
Shetty Sanjay KPresident, CenterWell
Tax withholdingHumana Common 888 $270.16 $239,897.64
Disclosure

SEC source: 0001969331-25-000003 · form4.xml · nonDerivative · entry 2

Shetty Sanjay K · CIK 0001969331 · President, CenterWell

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,678

F6 · shares: Shares disposed of represent payment of tax liability for shares vesting 12/15/25. No value was received in return.

Read SEC document
December 15, 2025 Filed Dec 17, 2025 19:15 UTC
Shetty Sanjay KPresident, CenterWell
Exercise / conversionHumana Common 1,968 $0.00 $0.00
Disclosure

SEC source: 0001969331-25-000003 · form4.xml · nonDerivative · entry 1

Shetty Sanjay K · CIK 0001969331 · President, CenterWell

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,566

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 15, 2025 Filed Dec 17, 2025 19:02 UTC
O'Hara Michelle A.Chief Human Resources Officer
Tax withholdingHumana Common 632 $270.16 $170,737.96
Disclosure

SEC source: 0001786783-25-000009 · form4.xml · nonDerivative · entry 2

O'Hara Michelle A. · CIK 0001786783 · Chief Human Resources Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,634

F2 · shares: Shares disposed of represent payment of tax liability for shares vesting on 12/15/25. No value was received in return.

F1 · balance_after: Includes 9,865 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(l)&(3) under the Company's 2019 Amended & Restated Plan.

Read SEC document
December 15, 2025 Filed Dec 17, 2025 19:02 UTC
O'Hara Michelle A.Chief Human Resources Officer
Exercise / conversionHumana Common 1,401 $0.00 $0.00
Disclosure

SEC source: 0001786783-25-000009 · form4.xml · nonDerivative · entry 1

O'Hara Michelle A. · CIK 0001786783 · Chief Human Resources Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,266

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 15, 2025 Filed Dec 17, 2025 18:58 UTC
Rechtin James A.President & CEO
Tax withholdingHumana Common 3,372 $270.16 $910,962.66
Disclosure

SEC source: 0002006065-25-000003 · form4.xml · nonDerivative · entry 2

Rechtin James A. · CIK 0002006065 · President & CEO

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 27,102

F7 · shares: Shares disposed of represent payment of tax liability for shares vesting on 12/15/25. No value was received in return.

F6 · balance_after: Includes 14,054 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan.

F1 · ownership.nature: All shares held in two revocable trust(s) for the benefit of reporting person and reporting person's spouse, with reporting person and spouse being sole trustees.

Read SEC document
December 15, 2025 Filed Dec 17, 2025 18:58 UTC
Rechtin James A.President & CEO
Exercise / conversionHumana Common 7,707 $0.00 $0.00
Disclosure

SEC source: 0002006065-25-000003 · form4.xml · nonDerivative · entry 1

Rechtin James A. · CIK 0002006065 · President & CEO

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 30,474

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · ownership.nature: All shares held in two revocable trust(s) for the benefit of reporting person and reporting person's spouse, with reporting person and spouse being sole trustees.

Read SEC document
December 15, 2025 Filed Dec 17, 2025 15:19 UTC
Ventura Joseph CChief Legal Officer
Exercise / conversionRestricted Stock Units · Derivative 360 $0.00 $0.00
Disclosure

SEC source: 0001768291-25-000006 · form4.xml · derivative · entry 11

Ventura Joseph C · CIK 0001768291 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Humana Common · 360 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F7 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F8 · derivative.exercise_date: Restricted stock units granted to reporting person on 02/24/2023, 33% of the award is vesting on 12/15/23, 12/15/24, and 12/15/25.

F8 · derivative.expiration_date: Restricted stock units granted to reporting person on 02/24/2023, 33% of the award is vesting on 12/15/23, 12/15/24, and 12/15/25.

Read SEC document
December 15, 2025 Filed Dec 17, 2025 15:19 UTC
Ventura Joseph CChief Legal Officer
Tax withholdingHumana Common 164 $270.16 $44,305.42
Disclosure

SEC source: 0001768291-25-000006 · form4.xml · nonDerivative · entry 4

Ventura Joseph C · CIK 0001768291 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,530

F10 · shares: Shares disposed of represent payment for tax liability on shares vesting vested on 12/15/25. No value was received in return.

F9 · balance_after: Includes 6,250 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan.

Read SEC document
December 15, 2025 Filed Dec 17, 2025 15:19 UTC
Ventura Joseph CChief Legal Officer
Exercise / conversionHumana Common 360 $0.00 $0.00
Disclosure

SEC source: 0001768291-25-000006 · form4.xml · nonDerivative · entry 3

Ventura Joseph C · CIK 0001768291 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,694

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 15, 2025 Filed Dec 17, 2025 15:19 UTC
Ventura Joseph CChief Legal Officer
Tax withholdingHumana Common 933 $270.16 $252,054.62
Disclosure

SEC source: 0001768291-25-000006 · form4.xml · nonDerivative · entry 2

Ventura Joseph C · CIK 0001768291 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,334

F10 · shares: Shares disposed of represent payment for tax liability on shares vesting vested on 12/15/25. No value was received in return.

Read SEC document
December 15, 2025 Filed Dec 17, 2025 15:19 UTC
Ventura Joseph CChief Legal Officer
Exercise / conversionHumana Common 2,046 $0.00 $0.00
Disclosure

SEC source: 0001768291-25-000006 · form4.xml · nonDerivative · entry 1

Ventura Joseph C · CIK 0001768291 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,267

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 15, 2025 Filed Dec 17, 2025 14:35 UTC
Renaudin George IIPresident, Insurance
Exercise / conversionRestricted Stock Units · Derivative 360 $0.00 $0.00
Disclosure

SEC source: 0001964078-25-000005 · form4.xml · derivative · entry 8

Renaudin George II · CIK 0001964078 · President, Insurance

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Humana Common · 360 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F4 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F5 · derivative.exercise_date: Restricted stock units granted to reporting person on 2/24/2023, 33% of the award is vesting on 12/15/23, 12/15/24, and 12/15/25.

F5 · derivative.expiration_date: Restricted stock units granted to reporting person on 2/24/2023, 33% of the award is vesting on 12/15/23, 12/15/24, and 12/15/25.

Read SEC document
December 15, 2025 Filed Dec 17, 2025 14:35 UTC
Renaudin George IIPresident, Insurance
Tax withholdingHumana Common 142 $270.16 $38,362.01
Disclosure

SEC source: 0001964078-25-000005 · form4.xml · nonDerivative · entry 4

Renaudin George II · CIK 0001964078 · President, Insurance

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,459

F8 · shares: Shares disposed of represent payment for tax liability on restricted stock vesting on 12/15/25. No value was received in return.

F6 · balance_after: Includes 9,059 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan.

Read SEC document
December 15, 2025 Filed Dec 17, 2025 14:35 UTC
Renaudin George IIPresident, Insurance
Exercise / conversionHumana Common 360 $0.00 $0.00
Disclosure

SEC source: 0001964078-25-000005 · form4.xml · nonDerivative · entry 3

Renaudin George II · CIK 0001964078 · President, Insurance

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,601

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 15, 2025 Filed Dec 17, 2025 14:35 UTC
Renaudin George IIPresident, Insurance
Tax withholdingHumana Common 830 $270.16 $224,228.65
Disclosure

SEC source: 0001964078-25-000005 · form4.xml · nonDerivative · entry 2

Renaudin George II · CIK 0001964078 · President, Insurance

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,241

F8 · shares: Shares disposed of represent payment for tax liability on restricted stock vesting on 12/15/25. No value was received in return.

Read SEC document
December 15, 2025 Filed Dec 17, 2025 14:35 UTC
Renaudin George IIPresident, Insurance
Exercise / conversionHumana Common 2,106 $0.00 $0.00
Disclosure

SEC source: 0001964078-25-000005 · form4.xml · nonDerivative · entry 1

Renaudin George II · CIK 0001964078 · President, Insurance

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,071

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 15, 2025 Filed Dec 17, 2025 14:26 UTC
Felter John-Paul W.SVP, Chief Accting Off & Cont.
Exercise / conversionRestricted Stock Units · Derivative 115 $0.00 $0.00
Disclosure

SEC source: 0001936662-25-000005 · form4.xml · derivative · entry 5

Felter John-Paul W. · CIK 0001936662 · SVP, Chief Accting Off & Cont.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Humana Common · 115 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F1 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F2 · derivative.exercise_date: Restricted stock units granted to reporting person on 2/24/2023, 33% of the award is vesting on 12/15/23, 12/15/24, and 12/15/25.

F2 · derivative.expiration_date: Restricted stock units granted to reporting person on 2/24/2023, 33% of the award is vesting on 12/15/23, 12/15/24, and 12/15/25.

Read SEC document
December 15, 2025 Filed Dec 17, 2025 14:26 UTC
Felter John-Paul W.SVP, Chief Accting Off & Cont.
Tax withholdingHumana Common 53 $270.16 $14,318.22
Disclosure

SEC source: 0001936662-25-000005 · form4.xml · nonDerivative · entry 4

Felter John-Paul W. · CIK 0001936662 · SVP, Chief Accting Off & Cont.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,734

F4 · shares: Shares disposed of represent payment for tax liability on restricted stock vesting 12/15/25. No value was received in return.

F3 · balance_after: Includes 748 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan.

Read SEC document
December 15, 2025 Filed Dec 17, 2025 14:26 UTC
Felter John-Paul W.SVP, Chief Accting Off & Cont.
Exercise / conversionHumana Common 115 $0.00 $0.00
Disclosure

SEC source: 0001936662-25-000005 · form4.xml · nonDerivative · entry 3

Felter John-Paul W. · CIK 0001936662 · SVP, Chief Accting Off & Cont.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,787

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 15, 2025 Filed Dec 17, 2025 14:26 UTC
Felter John-Paul W.SVP, Chief Accting Off & Cont.
Tax withholdingHumana Common 209 $270.16 $56,462.40
Disclosure

SEC source: 0001936662-25-000005 · form4.xml · nonDerivative · entry 2

Felter John-Paul W. · CIK 0001936662 · SVP, Chief Accting Off & Cont.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,672

F4 · shares: Shares disposed of represent payment for tax liability on restricted stock vesting 12/15/25. No value was received in return.

Read SEC document
December 15, 2025 Filed Dec 17, 2025 14:26 UTC
Felter John-Paul W.SVP, Chief Accting Off & Cont.
Exercise / conversionHumana Common 455 $0.00 $0.00
Disclosure

SEC source: 0001936662-25-000005 · form4.xml · nonDerivative · entry 1

Felter John-Paul W. · CIK 0001936662 · SVP, Chief Accting Off & Cont.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,881

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 01, 2025 Filed Nov 4, 2025 14:45 UTC
Smith GordonDirector
Exercise / conversionHumana Common 765 $0.00 $0.00
Disclosure

SEC source: 0001311487-25-000007 · form4.xml · nonDerivative · entry 1

Smith Gordon · CIK 0001311487 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 765

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
October 01, 2025 Filed Oct 3, 2025 13:13 UTC
Renaudin George IIPresident, Insurance
Exercise / conversionRestricted Stock Units · Derivative 609 $0.00 $0.00
Disclosure

SEC source: 0001964078-25-000003 · form4.xml · derivative · entry 6

Renaudin George II · CIK 0001964078 · President, Insurance

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Humana Common · 609 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F4 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F5 · derivative.exercise_date: Restricted stock units granted to reporting person on 10/1/2022, 100% of the award is vesting on 10/1/2025.

F5 · derivative.expiration_date: Restricted stock units granted to reporting person on 10/1/2022, 100% of the award is vesting on 10/1/2025.

Read SEC document
October 01, 2025 Filed Oct 3, 2025 13:13 UTC
Renaudin George IIPresident, Insurance
Tax withholdingHumana Common 240 $253.12 $60,748.80
Disclosure

SEC source: 0001964078-25-000003 · form4.xml · nonDerivative · entry 2

Renaudin George II · CIK 0001964078 · President, Insurance

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,071

F9 · shares: Shares disposed of represent payment for tax liability on restricted stock vesting on 10/1/25. No value was received in return.

Read SEC document
October 01, 2025 Filed Oct 3, 2025 13:13 UTC
Renaudin George IIPresident, Insurance
Exercise / conversionHumana Common 609 $0.00 $0.00
Disclosure

SEC source: 0001964078-25-000003 · form4.xml · nonDerivative · entry 1

Renaudin George II · CIK 0001964078 · President, Insurance

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,311

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · balance_after: Includes 11,165 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan.

Read SEC document
September 30, 2025 Filed Oct 2, 2025 17:07 UTC GrantRestricted Stock Units · Derivative 69 $257.79 $17,787.68
Disclosure

SEC source: 0001486426-25-000004 · form4.xml · derivative · entry 3

Feinberg David T · CIK 0001486426 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 638

Underlying: Humana Common · 69 shares

Expires not disclosed

F2 · security: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person. Stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1), per the Director's election.

F2 · derivative.exercise_price: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person. Stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1), per the Director's election.

F2 · derivative.exercise_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person. Stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1), per the Director's election.

F2 · derivative.expiration_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person. Stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1), per the Director's election.

Read SEC document
September 30, 2025 Filed Oct 2, 2025 15:50 UTC GrantRestricted Stock Units · Derivative 364 $257.79 $93,836.47
Disclosure

SEC source: 0001191504-25-000005 · form4.xml · derivative · entry 4

HILZINGER KURT J · CIK 0001191504 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,408

Underlying: Humana Common · 364 shares

Expires not disclosed

F3 · security: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person during a designated enrollment period in the year preceding the reported transactions. Stock units will be payable in Humana Inc. common stock on a 1-for-1basis, exempt pursuant to Rule 16(b)-3(d)(1), per the Director's election.

F3 · derivative.exercise_price: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person during a designated enrollment period in the year preceding the reported transactions. Stock units will be payable in Humana Inc. common stock on a 1-for-1basis, exempt pursuant to Rule 16(b)-3(d)(1), per the Director's election.

F3 · derivative.exercise_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person during a designated enrollment period in the year preceding the reported transactions. Stock units will be payable in Humana Inc. common stock on a 1-for-1basis, exempt pursuant to Rule 16(b)-3(d)(1), per the Director's election.

F3 · derivative.expiration_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person during a designated enrollment period in the year preceding the reported transactions. Stock units will be payable in Humana Inc. common stock on a 1-for-1basis, exempt pursuant to Rule 16(b)-3(d)(1), per the Director's election.

Read SEC document
September 30, 2025 Filed Oct 2, 2025 15:37 UTC
Smith GordonDirector
GrantRestricted Stock Units · Derivative 124 $257.79 $31,966.27
Disclosure

SEC source: 0001311487-25-000005 · form4.xml · derivative · entry 3

Smith Gordon · CIK 0001311487 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 378

Underlying: Humana Common · 124 shares

Expires not disclosed

F3 · derivative.exercise_price: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person during a designated enrollment period in the year preceding the reported transactions. Stock units will be payable in Humana Inc. common stock on a 1-for-1basis, exempt pursuant to Rule 16(b)-3(d)(1), per the Director's election.

F3 · derivative.exercise_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person during a designated enrollment period in the year preceding the reported transactions. Stock units will be payable in Humana Inc. common stock on a 1-for-1basis, exempt pursuant to Rule 16(b)-3(d)(1), per the Director's election.

F3 · derivative.expiration_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person during a designated enrollment period in the year preceding the reported transactions. Stock units will be payable in Humana Inc. common stock on a 1-for-1basis, exempt pursuant to Rule 16(b)-3(d)(1), per the Director's election.

Read SEC document
August 01, 2025 Filed Aug 5, 2025 17:22 UTC
Felter John-Paul W.SVP, Chief Accting Off & Cont.
Exercise / conversionRestricted Stock Units · Derivative 211 $0.00 $0.00
Disclosure

SEC source: 0001936662-25-000003 · form4.xml · derivative · entry 3

Felter John-Paul W. · CIK 0001936662 · SVP, Chief Accting Off & Cont.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Humana Common · 211 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F1 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F2 · derivative.exercise_date: Restricted stock units granted to reporting person on 8/1/2022, 33% of the award is vesting on 8/1/23, 8/1/24, and 8/1/25.

F2 · derivative.expiration_date: Restricted stock units granted to reporting person on 8/1/2022, 33% of the award is vesting on 8/1/23, 8/1/24, and 8/1/25.

Read SEC document
August 01, 2025 Filed Aug 5, 2025 17:22 UTC
Felter John-Paul W.SVP, Chief Accting Off & Cont.
Tax withholdingHumana Common 97 $248.42 $24,096.26
Disclosure

SEC source: 0001936662-25-000003 · form4.xml · nonDerivative · entry 2

Felter John-Paul W. · CIK 0001936662 · SVP, Chief Accting Off & Cont.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,881

F5 · shares: Shares disposed of represent payment for tax liability on restricted stock vesting 8/1/25. No value was received in return.

F4 · balance_after: Includes 1,203 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan.

Read SEC document
August 01, 2025 Filed Aug 5, 2025 17:22 UTC
Felter John-Paul W.SVP, Chief Accting Off & Cont.
Exercise / conversionHumana Common 211 $0.00 $0.00
Disclosure

SEC source: 0001936662-25-000003 · form4.xml · nonDerivative · entry 1

Felter John-Paul W. · CIK 0001936662 · SVP, Chief Accting Off & Cont.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,978

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 30, 2025 Filed Jul 2, 2025 20:18 UTC GrantRestricted Stock Units · Derivative 399 $242.82 $96,883.19
Disclosure

SEC source: 0001062993-25-012449 · form4.xml · derivative · entry 4

HILZINGER KURT J · CIK 0001191504 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,044

Underlying: Humana Common · 399 shares

Expires not disclosed

F3 · security: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person during a designated enrollment period in the year preceding the reported transactions. Stock units will be payable in Humana Inc. common stock on a 1-for-1basis, exempt pursuant to Rule 16(b)-3(d)(1), per the Director's election.

F3 · derivative.exercise_price: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person during a designated enrollment period in the year preceding the reported transactions. Stock units will be payable in Humana Inc. common stock on a 1-for-1basis, exempt pursuant to Rule 16(b)-3(d)(1), per the Director's election.

F3 · derivative.exercise_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person during a designated enrollment period in the year preceding the reported transactions. Stock units will be payable in Humana Inc. common stock on a 1-for-1basis, exempt pursuant to Rule 16(b)-3(d)(1), per the Director's election.

F3 · derivative.expiration_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person during a designated enrollment period in the year preceding the reported transactions. Stock units will be payable in Humana Inc. common stock on a 1-for-1basis, exempt pursuant to Rule 16(b)-3(d)(1), per the Director's election.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.